The efficacy and predictive factors of first-line immune checkpoint inhibitors for advanced non-small cell lung cancer with driver or non-driver gene alterations: a retrospective cohort study. - He Q; Guo XB; Chen YR; Gao XX; Zhao J; Zhong W; Chen MJ; Xu Y; Wang MZ (Journal of thoracic disease, 2026)